By monitoring ctDNA, the authors reveal the dynamic adaption of clonal populations in colorectal cancer patients treated with anti-EGFR therapy, suggesting that therapeutic re-challenge may have some benefit.
- Giulia Siravegna
- Benedetta Mussolin
- Alberto Bardelli